G protein-coupled receptors (GPCRs), which compose the largest class of drug targets, are critical signaling proteins that translate extracellular stimuli to mediate human physiology. As such, understanding GPCR signaling cascades will provide insight into the molecular mechanisms underlying these complex physiological processes, their perturbation in disease, and inform our ability to design more efficient therapeutics. In recent years, my lab and others have made a paradigm-shifting discovery that GPCRs can be activated after drug- induced internalization from the plasma membrane into endosomal compartments. However, one essential variable that remains unexplored is how the temporal dynamics of GPCR endosomal cAMP activity impact downstream signaling. In the current proposal, I will dissect the influence of the duration of GPCR activation in endosomes on downstream signaling, identify novel protein complexes that regulate receptor spatiotemporal signaling dynamics, and apply this knowledge to a physiologically relevant system?hippocampal neurons. By combining functional genomics, proteomics, and optogenetics, this proposal aims to provide a comprehensive understanding of how the temporal dynamics of GPCR signaling in endosomes regulates biological functions. This work is essential to comprehending the mechanisms of GPCR signaling and identifying novel signaling pathways, providing new targets for pharmacologic therapies.

Public Health Relevance

G protein-coupled receptors (GPCRs) are expressed widely throughout the body and mediate numerous physiologies and pathophysiologies. Recently, GPCRs were shown to signal from internal membranes and to give rise to location-specific downstream cellular responses; however, if and how the dynamics of signaling from these intracellular compartments may modulate responsiveness has not been addressed. The proposed experiments will investigate this aspect and thus are poised to provide novel insights into how these receptors transduce their myriad of downstream effects in the cell and identify new potential targets for pharmacological intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31NS120567-01A1
Application #
10233833
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Churn, Severn Borden
Project Start
2021-03-01
Project End
2024-02-29
Budget Start
2021-03-01
Budget End
2022-02-28
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705